PALO ALTO INVESTORS LP Revance Therapeutics, Inc. Transaction History

PALO ALTO INVESTORS LP portfolio value:

$118.93M
portfolio value

PALO ALTO INVESTORS LP quarter portfolio value change:

+95.37%
quarter

Revance Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 58.05M $27 4.40M
Q2 2022 share Decrease -0.24% -10.65K shares -25.22M $13.82 4.40M
Q1 2022 share Increase +1.06% 46.32K shares 14.79M $19.5 4.41M
Q4 2021 share Increase +36.46% 1.16M shares -17.89M $16.49 4.36M
Q3 2021 share 0.00% 0 shares -5.69M $27.86 3.20M
Q2 2021 share 0.00% 0 shares 5.41M $29.64 3.20M
Q1 2021 share Increase +19.77% 528.55K shares 13.73M $27.95 3.20M
Q4 2020 share Increase +34.01% 678.40K shares 25.61M $28.34 2.67M
Q3 2020 share Increase +17.05% 290.53K shares 8.53M $25.14 1.99M
Q2 2020 share Increase +176.82% 1.08M shares 32.50M $24.42 1.70M
Q1 2020 share Increase +595.01% 527.11K shares 7.67M $14.8 615.70K
Q4 2019 share Increase 0.00% 88.59K shares 1.43M $16.23 88.59K